Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?

<p>Abstract</p> <p>Background</p> <p>Single blastocyst transfer has the advantage of maximizing the fresh single pregnancy rate. However, in patients with a low number of good quality embryos on day 3, it remains unclear whether immediate embryo transfer or further embr...

Full description

Bibliographic Details
Main Authors: Verheyen Greta, Camus Michel, Van den Abbeel Etienne, Van Landuyt Lisbet, Stoop Dominic, Devroey Paul
Format: Article
Language:English
Published: BMC 2011-05-01
Series:Reproductive Biology and Endocrinology
Online Access:http://www.rbej.com/content/9/1/60
id doaj-61d661f778c94e97838647e00d854e5c
record_format Article
spelling doaj-61d661f778c94e97838647e00d854e5c2020-11-24T21:23:49ZengBMCReproductive Biology and Endocrinology1477-78272011-05-01916010.1186/1477-7827-9-60Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?Verheyen GretaCamus MichelVan den Abbeel EtienneVan Landuyt LisbetStoop DominicDevroey Paul<p>Abstract</p> <p>Background</p> <p>Single blastocyst transfer has the advantage of maximizing the fresh single pregnancy rate. However, in patients with a low number of good quality embryos on day 3, it remains unclear whether immediate embryo transfer or further embryo culture with blastocyst transfer is the most preferable option.</p> <p>Methods</p> <p>A retrospective cohort study was carried out in which the outcome of 590 fresh in vitro fertilization (IVF) cycles over a 15 months period and their cryo cycles were analyzed. A total of 341 patients cycles had an elective day 5 strategy independent of intermediate embryo evaluation while another 249 patients underwent a day 5 embryo transfer only if at least four embryos were available on day 3. Blastocyst vitrification was performed using a closed high security system.</p> <p>Results</p> <p>Demographics, stimulation parameters and embryological data were comparable in the two groups. Patients in the elective day 5 group had a lower fresh transfer rate (90.62% vs. 95.18%, p < 0.05) as compared to patients with a day 3 or day 5 embryo transfer policy. No difference was observed in the fresh live birth rate and multiple pregnancy rate per initiated cycle (32.84% vs. 28.92%; 1.17% vs 0%) The projected cumulative ongoing pregnancy rate compensating for double counting in case subjects have more than one pregnancy is not different (42.58% vs. 39.84%).</p> <p>Conclusions</p> <p>Despite lower fresh transfer rates, elective single blastocyst transfer yields a similar projected cumulative ongoing pregnancy rate as in a policy with cleavage stage or blastocyst transfer depending on a good quality embryo count on day 3.</p> http://www.rbej.com/content/9/1/60
collection DOAJ
language English
format Article
sources DOAJ
author Verheyen Greta
Camus Michel
Van den Abbeel Etienne
Van Landuyt Lisbet
Stoop Dominic
Devroey Paul
spellingShingle Verheyen Greta
Camus Michel
Van den Abbeel Etienne
Van Landuyt Lisbet
Stoop Dominic
Devroey Paul
Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?
Reproductive Biology and Endocrinology
author_facet Verheyen Greta
Camus Michel
Van den Abbeel Etienne
Van Landuyt Lisbet
Stoop Dominic
Devroey Paul
author_sort Verheyen Greta
title Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?
title_short Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?
title_full Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?
title_fullStr Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?
title_full_unstemmed Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?
title_sort should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?
publisher BMC
series Reproductive Biology and Endocrinology
issn 1477-7827
publishDate 2011-05-01
description <p>Abstract</p> <p>Background</p> <p>Single blastocyst transfer has the advantage of maximizing the fresh single pregnancy rate. However, in patients with a low number of good quality embryos on day 3, it remains unclear whether immediate embryo transfer or further embryo culture with blastocyst transfer is the most preferable option.</p> <p>Methods</p> <p>A retrospective cohort study was carried out in which the outcome of 590 fresh in vitro fertilization (IVF) cycles over a 15 months period and their cryo cycles were analyzed. A total of 341 patients cycles had an elective day 5 strategy independent of intermediate embryo evaluation while another 249 patients underwent a day 5 embryo transfer only if at least four embryos were available on day 3. Blastocyst vitrification was performed using a closed high security system.</p> <p>Results</p> <p>Demographics, stimulation parameters and embryological data were comparable in the two groups. Patients in the elective day 5 group had a lower fresh transfer rate (90.62% vs. 95.18%, p < 0.05) as compared to patients with a day 3 or day 5 embryo transfer policy. No difference was observed in the fresh live birth rate and multiple pregnancy rate per initiated cycle (32.84% vs. 28.92%; 1.17% vs 0%) The projected cumulative ongoing pregnancy rate compensating for double counting in case subjects have more than one pregnancy is not different (42.58% vs. 39.84%).</p> <p>Conclusions</p> <p>Despite lower fresh transfer rates, elective single blastocyst transfer yields a similar projected cumulative ongoing pregnancy rate as in a policy with cleavage stage or blastocyst transfer depending on a good quality embryo count on day 3.</p>
url http://www.rbej.com/content/9/1/60
work_keys_str_mv AT verheyengreta shouldasingleblastocysttransferpolicybeaclinicaldecisionorshoulditdependontheembryologicalevaluationonday3
AT camusmichel shouldasingleblastocysttransferpolicybeaclinicaldecisionorshoulditdependontheembryologicalevaluationonday3
AT vandenabbeeletienne shouldasingleblastocysttransferpolicybeaclinicaldecisionorshoulditdependontheembryologicalevaluationonday3
AT vanlanduytlisbet shouldasingleblastocysttransferpolicybeaclinicaldecisionorshoulditdependontheembryologicalevaluationonday3
AT stoopdominic shouldasingleblastocysttransferpolicybeaclinicaldecisionorshoulditdependontheembryologicalevaluationonday3
AT devroeypaul shouldasingleblastocysttransferpolicybeaclinicaldecisionorshoulditdependontheembryologicalevaluationonday3
_version_ 1725991140961812480